上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | PAR-4 (1-6)) |Protease Activated Receptor-4 (1-6), human |
| 编码 | [225779-44-2] |
| 别名 | PAR-4 (1-6)) |Protease Activated Receptor-4 (1-6), human |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | GYPGQV |
| 序列（三字母缩写） | H-Gly-Tyr-Pro-Gly-Gln-Val-OH (trifluoroacetate salt) |
| 基本描述 | This PAR-4 activating peptide caused secretion and aggregation of PAR-3 deficient mouse platelets. |
| 溶解度 | |
| 分子量 | 619.68 |
| 化学式 | C28H41N7O9 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents | ![PAR-4 (1-6)) |Protease Activated Receptor-4 (1-6), human 编码 [225779-44-2]](http://www.saliva.com.cn/wp-content/uploads/2022/10/20221005_633d2edd0c90c.png) |
| Figures | ![PAR-4 (1-6)) |Protease Activated Receptor-4 (1-6), human 编码 [225779-44-2]](http://www.saliva.com.cn/wp-content/uploads/2022/10/20221005_633d2edd6403f.jpg) |
| Reference | W.-F.Xu et al., Proc. Natl. Acad. Sci. USA, 95, 6642 (1998) H.Andersen et al., Proc. Natl. Acad. Sci. USA, 96, 11189 (1999) R.Kaufmann et al., J. Cancer Res. Clin. Oncol., 126, 91 (2000) |
| C端 | |
| N端 | |
| 化学桥 |